AJP - Renal Physiology, Vol 269, Issue 4 491-F499, Copyright © 1995 by American Physiological Society

ARTICLES

Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril

E. A. Burdmann, T. F. Andoh, C. C. Nast, A. Evan, B. A. Connors, T. M. Coffman, J. Lindsley and W. M. Bennett
Division of Nephrology, Hypertension, and Clinical Pharmacology, Oregon Health Sciences University, Portland 97201, USA.

The pathogenesis of renal scarring in chronic cyclosporin nephropathy is unknown. In this study, we evaluated the effects of renin-angiotensin system blockade by enalapril and losartan in a salt-dependent model of cyclosporin-associated chronic tubulointerstitial fibrosis (TIF). Rats kept on normal or low-salt diet were given cyclosporin, cyclosporin+enalapril, cyclosporin+losartan, cyclosporin+enalapril#losartan, or vehicle for 14 and 28 days. Cyclosporin reduced glomerular filtration rate (GFR) in rats fed either diet, but only salt-depleted animals developed significant TIF. Cyclosporin also impaired renal concentrating ability and caused tubular enzymuria. Renin-angiotensin system blockade decreased blood pressure (BP) and promoted afferent arteriolar vasodilatation. Losartan reduced plasma renin activity and prevented cyclosporin-induced increment of cortical alpha 1(I) procollagen mRNA. Renin-angiotensin blockade did not improve GFR and tubular function; however, it strikingly prevented TIF development, even in presence of very low BP. Rats treated with cyclosporin, hydralazine, and furosemide achieved BP values similar to losartan or enalapril groups, but there was no protection against interstitial fibrosis development. These results suggest that cyclosporin-related chronic interstitial injury is mediated by angiotensin II and that the mechanisms promoting the interstitial scarring can be dissociated from glomerular and tubular dysfunction in cyclosporin nephropathy.

This article has been cited by other articles:

				C. Li, C. W. Yang, J. H. Park, S. W. Lim, B. K. Sun, J. Y. Jung, S. B. Kim, Y. S. Kim, J. Kim, and B. K. Bang Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy Am J Physiol Renal Physiol, January 1, 2004; 286(1): F46 - F57. [Abstract] [Full Text] [PDF]

				C. Li, C. W. Yang, W. Y. Kim, J. Y. Jung, J. H. Cha, Y. S. Kim, J. Kim, W. M. Bennett, and B. K. Bang Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine Am J Physiol Renal Physiol, February 1, 2003; 284(2): F389 - F398. [Abstract] [Full Text] [PDF]

				J. L. Wilkinson-Berka, N. J. Gibbs, M. E. Cooper, S. L. Skinner, and D. J. Kelly Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1343 - 1349. [Abstract] [Full Text] [PDF]

				K. IIJIMA, K. HAMAHIRA, A. KOBAYASHI, H. NAKAMURA, and N. YOSHIKAWA Immunohistochemical Analysis of Renin Activity in Chronic Cyclosporine Nephropathy in Childhood Nephrotic Syndrome J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2265 - 2271. [Abstract] [Full Text]

				R. Oleggini, L. Musante, S. Menoni, G. Botti, M. D. Duca, M. Prudenziati, A. Carrea, R. Ravazzolo, and G. M. Ghiggeri Characterization of a DNA binding site that mediates the stimulatory effect of cyclosporin-A on type III collagen expression in renal cells Nephrol. Dial. Transplant., June 1, 2000; 15(6): 778 - 785. [Abstract] [Full Text] [PDF]

				Y. Sun, J. Zhang, J. Q. Zhang, and F. J. A. Ramires Local Angiotensin II and Transforming Growth Factor-{beta}1 in Renal Fibrosis of Rats Hypertension, May 1, 2000; 35(5): 1078 - 1084. [Abstract] [Full Text] [PDF]

				J. E. Toblli, I. Stella, E. de Cavanagh, M. Angerosa, F. Inserra, and L. Ferder Enalapril Prevents Tubulointerstitial Lesions by Hyperoxaluria Hypertension, January 1, 1999; 33(1): 225 - 231. [Abstract] [Full Text] [PDF]

				M. Mazzali, J. Kanellis, L. Han, L. Feng, Y.-Y. Xia, Q. Chen, D.-H. Kang, K. L. Gordon, S. Watanabe, T. Nakagawa, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism Am J Physiol Renal Physiol, June 1, 2002; 282(6): F991 - F997. [Abstract] [Full Text] [PDF]